Segui
Barbara L. Parsons
Barbara L. Parsons
Research Microbiologist, National Center for Toxicological Research, US FDA
Email verificata su fda.hhs.gov
Titolo
Citata da
Citata da
Anno
Nucleotide sequences from the adenovirus-2 genome.
TR Gingeras, D Sciaky, RE Gelinas, J Bing-Dong, CE Yen, MM Kelly, ...
Journal of Biological Chemistry 257 (22), 13475-13491, 1982
3501982
Accumulation of wound-inducible ACC synthase transcript in tomato fruit is inhibited by salicylic acid and polyamines
N Li, BL Parsons, D Liu, AK Mattoo
Plant Molecular Biology 18, 477-487, 1992
2561992
Genotypic selection methods for the direct analysis of point mutations
BL Parsons, RH Heflich
Mutation Research/Reviews in Mutation Research 387 (2), 97-121, 1997
1881997
Spontaneous deletions and duplications of sequences in the genome of cowpox virus.
DJ Pickup, BS Ink, BL Parsons, W Hu, WK Joklik
Proceedings of the National Academy of Sciences 81 (21), 6817-6821, 1984
1541984
Many different tumor types have polyclonal tumor origin: evidence and implications
BL Parsons
Mutation Research/Reviews in Mutation Research 659 (3), 232-247, 2008
1312008
Fixation and spread of somatic mutations in adult colonic epithelium
A Nicholson, C Olpe, A Hoyle, AS Thorsen, T Rus, M Colombe, ...
Cell Stem Cell 22, 909-918, 2018
1142018
Evaluation of clonal origin of malignant mesothelioma
S Comertpay, S Pastorino, M Tanji, R Mezzapelle, O Strianese, ...
Journal of translational medicine 12, 1-9, 2014
1032014
Multiclonal tumor origin: Evidence and implications
BL Parsons
Mutation research/reviews in mutation research 777, 1-18, 2018
662018
Personalized cancer treatment and the myth of KRAS wild-type colon tumors
BL Parsons, MB Myers
Discovery medicine 15 (83), 259-267, 2013
532013
Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR
PB McKinzie, BL Parsons
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 517 (1-2 …, 2002
522002
ACB-PCR quantification of K-RAS codon 12 GAT and GTT mutant fraction in colon tumor and non-tumor tissue
BL Parsons, KE Marchant-Miros, RR Delongchamp, TL Verkler, ...
Cancer investigation 28 (4), 364-375, 2010
492010
Breast cancer heterogeneity examined by high-sensitivity quantification of PIK3CA, KRAS, HRAS, and BRAF mutations in normal breast and ductal carcinomas
MB Myers, M Banda, KL McKim, Y Wang, MJ Powell, BL Parsons
Neoplasia 18 (4), 253-263, 2016
452016
K-RAS Mutation in the Screening, Prognosis and Treatment of Cancer
BL Parsons, F Meng
Biomarkers in medicine 3 (6), 757-769, 2009
442009
MED1: a central molecule for maintenance of genome integrity and response to DNA damage
BL Parsons
Proceedings of the National Academy of Sciences 100 (25), 14601-14602, 2003
412003
Allele-specific competitive blocker-PCR detection of rare base substitution
BL Parsons, PB McKinzie, RH Heflich
Molecular Toxicology Protocols, 235-245, 2005
402005
Detection of a mouse H-ras codon 61 mutation using a modified allele-specific competitive blocker PCR genotypic selection method
BL Parsons, RH Heflich
Mutagenesis 13 (6), 581-588, 1998
401998
Detection of basepair substitution mutation at a frequency of 1 × 10−7 by combining two genotypic selection methods, MutEx enrichment and allele‐specific …
BL Parsons, RH Heflich
Environmental and molecular mutagenesis 32 (3), 200-211, 1998
401998
Evaluation of MutS as a tool for direct measurement of point mutations in genomic DNA
BL Parsons, RH Heflich
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 374 (2 …, 1997
391997
Transcription of orthopoxvirus telomeres at late times during infection
BL Parsons, DJ Pickup
Virology 175 (1), 69-80, 1990
391990
Measurement of tumor-associated mutations in the nasal mucosa of rats exposed to varying doses of formaldehyde
F Meng, E Bermudez, PB McKinzie, ME Andersen, HJ Clewell III, ...
Regulatory Toxicology and Pharmacology 57 (2-3), 274-283, 2010
382010
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20